Recommended Reading List |
1. Checkoway, H., Lundin, J. I., & Kelada, S. N. (2011). Neurodegenerative diseases. IARC scientific publications, (163), 407-419.2. Ferrisi, R., Ceni, C., Bertini, S., Macchia, M., Manera, C., & Gado, F. (2021). Medicinal Chemistry approach, pharmacology and neuroprotective benefits of CB2R modulators in neurodegenerative diseases. Pharmacological Research, 170, 105607.3. Cavalli, A., Bolognesi, M. L., Minarini, A., Rosini, M., Tumiatti, V., Recanatini, M., & Melchiorre, C. (2008). Multi-target-directed ligands to combat neurodegenerative diseases. Journal of medicinal chemistry, 51(3), 347-372. |
Catalog Content |
Neurodegenerative Diseases: Definitions, Classifications; Effective Drugs in Neurodegenerative Diseases: Chemical classification of drugs; Examination of Chemical Structures of Drugs, Mechanisms of action of drugs; Target Sites in Neurodegenerative Diseases: Enzymes, Receptors, Topological investigations, Structure-effect relationships; Current Approaches in the Treatment of Neurodegenerative Diseases; New Drug Design Approaches in Neurodegenerative Diseases. |